High-dose vitamin C infusion for advanced solid tumors
Part of Cancer clinical trials.
This trial tests a special high-dose vitamin C infusion, given based on how your body processes it, for people with advanced solid tumors. It aims to see if this vitamin C therapy can be safely combined with your current or new chemotherapy to help control the cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 75 years old.
- Your cancer must be an advanced or metastatic solid tumor that hasn't responded to standard treatments or has progressed.
- You need to have at least one measurable tumor and an ECOG score of 0 or 1 (able to do light housework or be fully active).
- You should not have calcium oxalate kidney stones, G6PD deficiency, or uncontrolled diabetes (fasting blood sugar over 10).
- Your cancer's catalase test must come back negative, and you can't have brain metastases or active infections like TB, HIV, or hepatitis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests adding high-dose vitamin C (ascorbate) to a standard chemotherapy combination for people with muscle-invasive bladder cancer who cannot take or choose not to take cisplatin. The goal is to find a more affordable and effective treatment option.
This study tests a new drug called CVL006 for people with advanced solid tumors that have stopped responding to standard treatments. It aims to see if the drug is safe and how well it works against different types of cancer.
This trial is testing a new CAR-T cell therapy given as an injection for people with advanced or metastatic solid tumors that have stopped responding to standard treatments. CAR-T therapy uses your own immune cells to target and attack cancer cells. It may be an option if you have tried other treatments and they are no longer working.
This trial tests two experimental drugs given together to treat advanced solid tumors that have not responded to previous treatments. The goal is to see if the combination helps shrink or control the cancer, and the study is for people who are otherwise in fairly good health.
This trial tests a new drug called CS23546 for people with advanced solid tumors or lymphoma that have not responded to other treatments. Researchers will check your tumor for certain markers (PD-L1 and MSI) to see if the drug might work for you.
This trial tests an experimental drug called MHB046C for people with advanced solid tumors that have stopped responding to standard treatments. The goal is to see if it can shrink tumors or slow their growth.
Hear when a new Vitamin C trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.